Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (scIgG) (SCIGG-181)

Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-malaria antigen and anti-TLR1 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget professional antigen-presenting cells (APCs) including DCs or NK cells to malaria antigen. It is designed for the research of Malaria therapy.

Datasheet INQUIRY

Specifications

Targets

malaria antigen & TLR1

Type

Single chain IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Malaria

Targets

Target 1

malaria antigen

Alternative Names

malaria antigen; parasitic protozoans

Target 2

TLR1

Gene ID

7096

UniProt ID

Q15399

Alternative Names

CD281; TIL; TIL. LPRS5; rsc786; TLR1; Toll-like receptor 1; TLR

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "malaria antigen & TLR1"

See other bsAb targets related to "malaria antigen"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (scIgG) (SCIGG-181). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (scIgG) (CAT#: SCIGG-181)

Specifications

Targets

Customer Reviews and Q&As